The lack of imaging biomarkers is a key obstacle to the development of treatment for progressive multiple sclerosis. While diffusion MRI is a promising biomarker, variability among scanners may limit its use. We examine site-related variability among multiple sclerosis patients to inform the design of multicenter trials.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords